“We shared at the investor conference that Surest was available in 12 states on an insured basis with a year-end target for this year of upwards of 35 states.”

In context

“for the question. And yes, our momentum in the first quarter clearly continued the momentum we had in the back half of last year and puts us well on track, as John said in his prepared remarks, to meet our investor conference goal – investor conference targets rather, of $850 million to $1.5 billion [ph] growth. Surest was a component of that. Surest was the component, about – accounting for about 25% of our growth in the quarter as that product continues to be adopted. We have shared before that one in nine of our national accounts actually have that product today. We are continuing to see that expand down into the middle market currently as the growth of that product continues. And we also are beginning to experience take-up now on a fully insured basis for that product on a risk basis. We shared at the investor conference that Surest was available in 12 states on an insured basis with a year-end target for this year of upwards of 35 states. We currently offer that product in 25 states. So, it is a meaningful contributor to our growth, and we expect it to be so for the remainder of the year and into the future. Thanks for the question, Erin. Andrew Witty: Dan, thank you so much. And I just might add something here, Erin, as well. I mean I think you can see in this Q, you saw it as we rolled into the second half of last year, we are optimistic for the rest of this year. I said earlier that we are expecting continued robust growth on commercial insurance into ‘24. We really feel like this engine has let up again and it’s super important for the organization. Alongside the fantastic growth you are seeing in the government books of business in Medicaid and Medicare. We are now seeing the commercial business really come to the for”